VAERS reports by lot

Moderna COVID-19 lot 001BZ1A: VAERS reports

22 VAERS reports list lot 001BZ1A as a Moderna COVID-19 vaccine, received between 2021-03-11 and 2022-04-13. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
22
Reports
9%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2739%
Neurological1319%
Injection-site / Local reaction69%
Gastrointestinal46%
Musculoskeletal46%
Dermatological (non-injection-site)46%
Allergic / Anaphylactic34%
Psychiatric / Neuropsychiatric34%
Cardiac / Cardiovascular23%
Respiratory23%
Reproductive / Menstrual11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California4
Illinois3
New York2
North Carolina2
Arizona2
Connecticut1
Delaware1
Vermont1
Minnesota1
Wisconsin1
Idaho1
Nevada1

Reports by month received

2021-039
2021-043
2021-054
2021-071
2021-081
2021-111
2022-011
2022-021
2022-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.